𩺠å
§ç§å°ç§èåç
1ïžâ£ Cholera Outbreak Management
- éå ± immediately (notifiable globally)
- Mass ORS distribution (cholera treatment centers)
- WHO cholera kit (ORS, IV fluid, antibiotic, lab supplies)
- Water + sanitation intervention (chlorination, sanitation)
- Vaccine deployment (Shanchol, Euvichol-Plus from stockpile)
- å
ç«¥ + è priority
2ïžâ£ V. vulnificus é é² (Patient Education)
- Cirrhotic / hemochromatosis ç
人 NO raw oyster
- æµ·æ°Ž wound â ç«å³ wash + abx if çŽ
è
«
- ææ (May-Oct in Gulf Coast)
- å¥ä¿ / public health education campaigns
- ç§é«åž« hint: è硬å + äžæ sepsis + æµ·æ°Ž / æµ·é®®æ¥è§ž â å¿
ID consult, suspect V. vulnificus
3ïžâ£ Climate Change + Vibrio Expansion
- Sea surface temp â â V. vulnificus extending range
- 2023 Baltic outbreak (NE Europe)
- USA NE Coast (Connecticut, NY) â northern expansion
- èŠ public health: high-risk patient education + clinician awareness
4ïžâ£ Diagnostics (Modern)
- BioFire GI panel includes V. cholerae + V. parahaemolyticus
- MALDI-TOF lab ID
- å€ Vibrio species accurate ID
- AST: doxy R rare; FQ R emerging
5ïžâ£ Antimicrobial Resistance
- O1 V. cholerae â TMP-SMX R common (older 1st-line)
- FQ R in some endemic
- Doxy generally still effective
- Azithro reliable
6ïžâ£ Pregnancy + Cholera
- Single-dose doxy / azithromycin acceptable (urgent)
- ORS å emphasis
7ïžâ£ å¥ä¿ / Taiwan
- Cholera â éå ± (rare local, imported)
- V. parahaemolyticus â é« incidence (æµ·é®® culture); éå ± outbreak
- V. vulnificus â éå ± SSTI / sepsis; æŒæž¯ occupational
- å¥ä¿ doxy / ceftriaxone â admit indication
- Cholera vaccine èªè²» (æ
é ID)
8ïžâ£ ASP
- äž routine antibiotic for V. parahaemolyticus healthy
- V. vulnificus suspected â broad empirical immediately (donât wait culture)
- De-escalate to doxy + ceftriaxone